Science Explorer Back to mapMap
Discussion
Researcher · Novo Nordisk Foundation · Denmark

Ivo Alexander Hendriks

Ivo Alexander Hendriks publishes mostly in Molecular Biology, Oncology and Spectroscopy, on topics such as Ubiquitin and proteasome pathways, DNA Repair Mechanisms and PARP inhibition in cancer therapy.

ORCID 0000-0002-1439-3701 OpenAlex
World rank
#78,234
of 7,710,434 ranked researchers
Rank in Denmark
#444
of 43,819
Works
101
Citations
4.7k
Citations per work
47.0
h-index
30
i10-index 53Top 15% in Molecular Biology
Ivo Alexander Hendriks

What does Ivo Alexander Hendriks research?

Ivo Alexander Hendriks's work is mostly in Biochemistry, Genetics and Molecular Biology (52%), Medicine (14%), Chemistry (6%).

Life Sciences: 52 works · 51.5% of their workBiochemistry, Genetics and Molecular Biology: 52 works · 51.5% of their workMolecular Biology: 48 works · 47.2% of their workGenetics: 4 works · 4.3% of their workEverything else: 24 works · 24.1% of their workHealth Sciences: 15 works · 14.5% of their workMedicine: 15 works · 14.5% of their workOncology: 11 works · 11.3% of their workCardiology and Cardiovascular Medicine: 3 works · 3.2% of their workPhysical Sciences: 10 works · 9.9% of their workChemistry: 6 works · 6.4% of their workSpectroscopy: 6 works · 6.4% of their workEnvironmental Science: 4 works · 3.5% of their workEcology: 4 works · 3.5% of their workTHEIR WORKIvo AlexanderHendriks101works
Life Sciences52%Physical Sciences10%Health Sciences14%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology5251.5%
  2. Everything else2424.1%
    1. Medicine1514.5%
    1. Chemistry66.4%
    2. Environmental Science43.5%
  1. 1Molecular Biology47% of their works
  2. 2Oncology11% of their works
  3. 3Spectroscopy6% of their works
  4. 4Genetics4% of their works
  5. 5Ecology4% of their works
  6. 6Cardiology and Cardiovascular Medicine3% of their works

Research topics

Which keywords describe Ivo Alexander Hendriks's research?

The keywords of their largest research topics: Cancer Therapy, Proteasome, Ubiquitin, Homologous Recombination, DNA Damage, Repair, BRCA Mutation and PARP Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Therapy633 topics
  2. Proteasome391 topic
  3. Ubiquitin391 topic
  4. Homologous Recombination312 topics
  5. DNA Damage181 topic
  6. Repair181 topic
  7. BRCA Mutation131 topic
  8. PARP Inhibitors131 topic
  9. Mass Spectrometry121 topic
  10. Proteomics121 topic
  11. Fibroblast Activation Protein111 topic
  12. Tumor Microenvironment111 topic
  13. Ecology101 topic
  14. Ribosome101 topic
  15. Translation101 topic
  16. Virus101 topic
  17. RNA methylation91 topic
  18. m6A-seq91 topic

Where does Ivo Alexander Hendriks work?

Ivo Alexander Hendriks's main affiliation in the publication record is Novo Nordisk Foundation, Denmark.

How many publications and citations does Ivo Alexander Hendriks have?

OpenAlex counts 101 works and 4,743 citations for Ivo Alexander Hendriks, an h-index of 30, ranking #78,234 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ivo Alexander Hendriks. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.